In a preclinical study, Cedars-Sinai investigators found that boosting angiotensin-converting enzyme (ACE) in key immune ...

A new preclinical study has found exposure to nanoplastics may contribute to the rapid progression of Alzheimer's disease and ...

Findings from a Phase III study highlight the demonstrated action of donanemab-azbt (brand name Kisunla) in slowing the ...

Learn how foods like berries, leafy greens, fish, and olive oil may support brain health and reduce your risk of dementia.

A history of traumatic brain injury was linked to long-term cognitive decline involving speech functions, specifically where ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Helen Dennis is a nationally recognized leader on issues of aging and the new retirement with academic, corporate and ...

Two already-approved medications may help overturn brain changes caused by Alzheimer's disease, according to a recent study ...

Differences in outcomes between patients with early Alzheimer’s disease who used lecanemab and matched controls increased ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

Explore the growth potential of the Alzheimer's disease-modifying therapies (DMTs) market as lecanemab gains FDA approval in 2023. With several late-stage trials underway, anticipate market shifts ...